Related Experiment Video

Updated: Apr 1, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K

ML-7 amplifies the quinocetone-induced cell death through akt and MAPK-mediated apoptosis on HepG2 cell line

Yan Zhou1, Shen Zhang1, Sijun Deng1

  • 1a Department of Pharmacology and Toxicology , College of Veterinary Medicine, China Agricultural University , Haidian , Beijing , PR China.

Toxicology Mechanisms and Methods
|October 9, 2015
PubMed

Insights

The combination of ML-7 and quinocetone enhances apoptosis in liver cancer cells. This synergistic effect involves specific signaling pathways, offering a promising new strategy for hepatocellular carcinoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited effective therapeutic options.
  • Understanding the molecular mechanisms underlying HCC cell death is crucial for developing novel treatment strategies.

Purpose of the Study:

  • To evaluate the synergistic effects of quinocetone and ML-7 on apoptosis induction in preclinical hepatocellular carcinoma models.
  • To elucidate the underlying signaling pathways involved in the combined treatment of quinocetone and ML-7 in HepG2 cells.

Main Methods:

  • Analysis of apoptosis induction by quinocetone and ML-7 in HepG2 cell lines.
  • Investigation of the effects on caspase cleavage, Bax/Bcl-2 ratio, and key signaling pathways (Akt, p-38, ERK, JNK).
  • Assessment of apoptosis modulation using Akt activator, p-38 inhibitor, ERK inhibitor, and JNK inhibitor.

Main Results:

  • ML-7 (at non-toxic concentrations) sensitized HepG2 cells to quinocetone-induced cytotoxicity and enhanced apoptosis.
  • The combination triggered caspase-8 cleavage, increased the Bax/Bcl-2 ratio, and led to Bid, caspase-9, and caspase-3 cleavage.
  • ML-7 modulated signaling pathways by weakening Akt activation while strengthening p-38, ERK, and JNK phosphorylation, with p-38 phosphorylation being critical for synergism.

Conclusions:

  • The rational combination of quinocetone and ML-7 demonstrates a promising synergistic approach to induce apoptosis in hepatocellular carcinoma.
  • The findings highlight the critical role of p-38 phosphorylation and the counteracting effects of Akt, ERK, and JNK pathways in this synergistic apoptosis induction.
  • Further investigation is warranted to explore the therapeutic potential of this combination in HCC treatment.
Keywords:
AktHepG2MAPKML-7apoptosisquinocetone

More Related Videos

Working with Auditory HEI-OC1 Cells08:56

Working with Auditory HEI-OC1 Cells

Published on: September 3, 2016

16.1K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
11.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K